| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0004 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0007 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.0008 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |